Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study

Source: Article title.

All patients were over 18 years old and were diagnosed with TAO by a professional clinician based on clinical manifestations and the orbital CT results.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study

Cohort study · Frontiers in Immunology · 2026

Original publication title

Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study

Ling Wang; Jingya Wang; Huayang Xu; Yushi Sun; Xingchen Zhou; Yu Chen; Jiarui Zhao; Jinbo Zhang; Hui Guo; Bingyin Shi; Yue Wang; Meng Zhang

Copyright © 2026 Wang, Wang, Xu, Sun, Zhou, Chen, Zhao, Zhang, Guo, Shi, Wang and Zhang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Δ25(OH)D is an independent predictor of IVGC response in TAO. Monitoring dynamic changes in serum 25(OH)D during therapy and targeting a minimum increase of 2.7 ng/mL may be associated with improved treatment outcomes, particularly in male, elderly, and VitD-deficient subpopulations.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Intravenous glucocorticoids (IVGC) represent first-line therapy for active moderate-to-severe thyroid-associated ophthalmopathy (TAO). The relationship between vitamin D (VitD) and IVGC efficacy in TAO remains undefined.

Source: Background

Abstract: What methods does the paper describe?

This retrospective study grouped TAO patients completing IVGC therapy with standardized VitD/calcium supplementation at First Affiliated Hospital of Xi’an Jiaotong University (2015 to 2019). Serum 25-hydroxyvitamin D (25(OH)D) and bone markers were measured pre/post-treatment. Multivariate regression and ROC analysis identified predictors.

Source: Methods

Abstract: Results

In total, 52 TAO patients were enrolled, including 33 responders and 19 non-responders. Non-responders had significantly higher baseline triglycerides, thyroxine and longer duration of ophthalmopathy. Responders exhibited higher baseline β-CTX and N-MID OC. Notably, 73.08% of patients had baseline 25(OH)D deficiency (<20 ng/mL), with a significant 25(OH)D increase observed only in responders (P = 0.02). Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.

Multivariate analysis confirmed Δ25(OH)D as an independent predictor after adjustment for confounders (adjusted OR = 1.205, 95% CI:1.033 to 1.405; P = 0.017). ROC analysis showed Δ25(OH)D predicted response (AUC = 0.732, P = 0.006), with an optimal cutoff of +2.7 ng/mL. Predictive power was enhanced in males, patients ≥50 years, and baseline 25(OH)D: deficient subgroups.

Source: Results

Abstract: Conclusion

Δ25(OH)D is an independent predictor of IVGC response in TAO. Monitoring dynamic changes in serum 25(OH)D during therapy and targeting a minimum increase of 2.7 ng/mL may be associated with improved treatment outcomes, particularly in male, elderly, and VitD-deficient subpopulations.

Source: Conclusion
Authors’ abstract

Background

Intravenous glucocorticoids (IVGC) represent first-line therapy for active moderate-to-severe thyroid-associated ophthalmopathy (TAO). The relationship between vitamin D (VitD) and IVGC efficacy in TAO remains undefined.

Methods

This retrospective study grouped TAO patients completing IVGC therapy with standardized VitD/calcium supplementation at First Affiliated Hospital of Xi’an Jiaotong University (2015 to 2019). Serum 25-hydroxyvitamin D (25(OH)D) and bone markers were measured pre/post-treatment. Multivariate regression and ROC analysis identified predictors.

Results

In total, 52 TAO patients were enrolled, including 33 responders and 19 non-responders. Non-responders had significantly higher baseline triglycerides, thyroxine and longer duration of ophthalmopathy. Responders exhibited higher baseline β-CTX and N-MID OC. Notably, 73.08% of patients had baseline 25(OH)D deficiency (<20 ng/mL), with a significant 25(OH)D increase observed only in responders (P = 0.02). Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.

Multivariate analysis confirmed Δ25(OH)D as an independent predictor after adjustment for confounders (adjusted OR = 1.205, 95% CI:1.033 to 1.405; P = 0.017). ROC analysis showed Δ25(OH)D predicted response (AUC = 0.732, P = 0.006), with an optimal cutoff of +2.7 ng/mL. Predictive power was enhanced in males, patients ≥50 years, and baseline 25(OH)D: deficient subgroups.

Conclusion

Δ25(OH)D is an independent predictor of IVGC response in TAO. Monitoring dynamic changes in serum 25(OH)D during therapy and targeting a minimum increase of 2.7 ng/mL may be associated with improved treatment outcomes, particularly in male, elderly, and VitD-deficient subpopulations.

Publication and source details

Original title: Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study

Ling Wang; Jingya Wang; Huayang Xu; Yushi Sun; Xingchen Zhou; Yu Chen; Jiarui Zhao; Jinbo Zhang; Hui Guo; Bingyin Shi; Yue Wang; Meng Zhang

Frontiers in Immunology · 2026

* Correspondence: Meng Zhang, mengbaba19921025@163.com

†ORCID: Meng Zhang, orcid.org/0000-0002-4640-8891

Copyright © 2026 Wang, Wang, Xu, Sun, Zhou, Chen, Zhao, Zhang, Guo, Shi, Wang and Zhang.2026Wang, Wang, Xu, Sun, Zhou, Chen, Zhao, Zhang, Guo, Shi, Wang and Zhanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. National Natural Science Foundation of China10.13039/501100001809 82201238 First Affiliated Hospital of Xi’an Jiaotong University10.13039/100031934 2025-MS-015The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Natural Science Foundation of China (NSFC) (grant number 82201238) and the Institutional Foundation of The First Affiliated Hospital of Xi’an Jiaotong University (grant number 2025-MS-015).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:23:05.287968+00:00

DOI: 10.3389/fimmu.2026.1778702 · PMC13139022